PharmaCyte Biotech, Inc. Quarterly Common Stock, Shares Authorized from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
PharmaCyte Biotech, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q1 2011 to Q2 2024.
  • PharmaCyte Biotech, Inc. Common Stock, Shares Authorized for the quarter ending July 31, 2024 was 200M shares, a 50% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 200M +66.7M +50% Jul 31, 2024 10-Q 2024-09-17
Q1 2024 200M 0 0% Apr 30, 2024 10-Q 2024-09-17
Q4 2023 200M +167M +500% Jan 31, 2024 10-Q 2024-03-18
Q3 2023 200M +167M +500% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 133M +100M +300% Jul 31, 2023 10-Q 2023-09-18
Q1 2023 200M +66.7M +50% Apr 30, 2023 10-K 2024-08-13
Q4 2022 33.3M 0 0% Jan 31, 2023 10-Q 2023-03-16
Q3 2022 33.3M 0 0% Oct 31, 2022 10-Q 2022-12-14
Q2 2022 33.3M -50B -99.9% Jul 31, 2022 10-Q 2022-09-14
Q1 2022 133M +100M +300% Apr 30, 2022 10-K 2023-07-31
Q4 2021 33.3M -2.46B -98.7% Jan 31, 2022 10-Q 2022-03-15
Q3 2021 33.3M -2.46B -98.7% Oct 31, 2021 10-Q 2021-12-14
Q2 2021 50B +47.5B +1908% Jul 11, 2021 10-Q 2021-12-14
Q1 2021 33.3M -1.63B -98% Apr 30, 2021 10-K 2022-07-28
Q4 2020 2.49B 0 0% Jan 31, 2021 10-Q 2021-03-12
Q3 2020 2.49B 0 0% Oct 31, 2020 10-Q 2020-12-11
Q2 2020 2.49B +1B +67.1% Jul 31, 2020 10-Q 2020-09-11
Q1 2020 1.66B -830M -33.3% Apr 30, 2020 10-K 2021-08-10
Q4 2019 2.49B +1B +67.1% Jan 31, 2020 10-Q 2020-03-13
Q3 2019 2.49B +1B +67.1% Oct 31, 2019 10-Q 2019-12-23
Q2 2019 1.49B 0 0% Jul 31, 2019 10-Q 2019-09-13
Q1 2019 2.49B +1B +67.1% Apr 30, 2019 10-K 2020-08-13
Q4 2018 1.49B 0 0% Jan 31, 2019 10-Q 2019-03-14
Q3 2018 1.49B 0 0% Oct 31, 2018 10-Q 2018-12-14
Q2 2018 1.49B 0 0% Jul 31, 2018 10-Q 2018-09-12
Q1 2018 1.49B 0 0% Apr 30, 2018 10-K 2019-08-13
Q4 2017 1.49B 0 0% Jan 31, 2018 10-Q 2018-03-19
Q3 2017 1.49B 0 0% Oct 31, 2017 10-Q 2017-12-14
Q2 2017 1.49B 0 0% Jul 31, 2017 10-Q 2017-09-13
Q1 2017 1.49B 0 0% Apr 30, 2017 10-K 2018-07-20
Q4 2016 1.49B 0 0% Jan 31, 2017 10-Q/A 2017-03-13
Q3 2016 1.49B 0 0% Oct 31, 2016 10-Q 2016-12-02
Q2 2016 1.49B 0 0% Jul 31, 2016 10-Q 2016-09-06
Q1 2016 1.49B 0 0% Apr 30, 2016 10-K 2017-07-27
Q4 2015 1.49B 0 0% Jan 31, 2016 10-Q 2016-03-08
Q3 2015 1.49B 0 0% Oct 31, 2015 10-Q/A 2016-01-19
Q2 2015 1.49B 0 0% Jul 31, 2015 10-Q/A 2016-01-19
Q1 2015 1.49B 0 0% Apr 30, 2015 10-K 2016-07-29
Q4 2014 1.49B 0 0% Jan 31, 2015 10-Q 2015-03-13
Q3 2014 1.49B 0 0% Oct 31, 2014 10-Q 2014-12-15
Q2 2014 1.49B 0 0% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 1.49B 0 0% Apr 30, 2014 10-K/A 2016-01-19
Q4 2013 1.49B 0 0% Jan 31, 2014 10-Q 2014-03-17
Q3 2013 1.49B 0 0% Oct 31, 2013 10-Q 2013-12-16
Q2 2013 1.49B 0 0% Jul 31, 2013 10-Q 2013-09-16
Q1 2013 1.49B 0 0% Apr 30, 2013 10-K 2014-08-04
Q4 2012 1.49B 0 0% Jan 31, 2013 10-Q 2013-03-26
Q3 2012 1.49B 0 0% Oct 31, 2012 10-Q 2012-12-26
Q2 2012 1.49B 0 0% Jul 31, 2012 10-Q 2012-09-19
Q1 2012 1.49B 0 0% Apr 30, 2012 10-K 2013-07-29
Q4 2011 1.49B Jan 31, 2012 10-Q 2012-03-21
Q3 2011 1.49B Oct 31, 2011 10-Q 2011-12-15
Q2 2011 1.49B Jul 31, 2011 10-Q/A 2011-09-20
Q1 2011 1.49B Apr 30, 2011 10-K 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.